Loading…
STVN
Stevanato Group S.p.A.
NYSE· Healthcare· Medical Instruments & Supplies· CUSIP T9224W109
$19.50+3.61%Price as of Oct 23, 00:54 UTC · updated once a day, after the close
At a glance
Stevanato Group S.p.A. (STVN) is listed on NYSE and classified in Medical Instruments & Supplies, part of the Healthcare sector. It is headquartered in Piombino Dese, Italy and has 6,010 employees. The company is worth $5.33B and trades at 33.1x its earnings of the last twelve months; the median for its sector is 24.3x. Revenue was €1.19B in fiscal 2025, up 7.4% from the year before. Net income was €139.84M. The share price is 30.3% below its 52-week high of $27.99. It pays a dividend yielding 0.31%. 2 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Ken Griffin (Citadel Advisors), at $6.67M. In that quarter, 2 of them reduced the position. Over the last 30 days, company insiders sold $293.45K of its stock on the open market and bought none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $5.33B
- P/E
- 33.1x
- Forward P/E
- 23.5x
- P/B
- 3.1x
- Dividend yield
- 0.31%
- Payout
- 10.17%
- EPS
- $0.59
- ROE
- 9.13%
- Profit margin
- 10.99%
- Revenue growth
- +7.80%
- Beta
- 0.78
- 52-week high
- $27.99
- 52-week low
- $12.89
History
Year by year, from the annual reports; dividends from the payments themselves.
Revenue, debt and profit are in EUR, the currency the company reports in — not converted to dollars. Dividends are in dollars.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -20.8% over 5Y.
today you would have $747.38▼ -25.3%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $20.12 | $21.79 | $27.29 | $17.97 | |
| EPS | €0.51 | €0.43 | €0.55 | €0.54 | |
| Dividend yield | 0.28% | 0.31% | 0.27% | 0.21% | 0.30% |
| Profit margin | 12.60% | 11.79% | 10.67% | 13.42% | 14.52% |
| ROE | 11.13% | 9.41% | 8.39% |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
$9.20
Square root of 22.5 × earnings × book value. Blind to intangibles, so it undervalues software and brands.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
$14.33
Median P/E of 24.3 among peers in the sector.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Dividends
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| HAEHaemonetics Corp | $116.16 | 56.1x | 6.3x | 0.00% | 11.20% | $5.28B |
| ORKAOruka Therapeutics, Inc. | $81.15 | — | 4.5x | 0.00% | -18.23% | $5.37B |
| KODKodiak Sciences Inc. | $85.78 | — | 88.1x | 0.00% | -368.37% | $5.39B |
| PTCTPtc Therapeutics Inc | $63.04 |
About the company
- 6,010
- Piombino Dese, Italy